Autolus Therapeutics to Participate in Upcoming Investor Conferences
LONDON, May 29, 2025 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), an early commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, announces that the Company will participate in upcoming investor conferences.
William Blair 45th Annual Growth Stock Conference
Management to host investor meetings
Date: June 3, 2025
Location: Chicago, IL
Jefferies Global Healthcare Conference
Fireside Chat Presentation
Date and time: June 5, 2025; 3:10pm EDT / 20:10pm BST
Location: New York, NY
Presenter: Chief Executive Officer Dr. Christian Itin
Goldman Sachs 46th Annual Global Healthcare Conference
Fireside Chat Presentation
Date and time: June 11, 2025; 1:20pm EDT / 18:20 BST
Location: Miami, FL
Presenter: Chief Financial Officer Rob Dolski
A webcast of the fireside chats will be available on the “Events” page in the “Investor Relations & Media” section of the Company’s website at https://www.autolus.com/investor-relations-media/events/. A replay of the webcast will be archived on the Company’s website for 90 days following the presentation.
About Autolus Therapeutics plc
Autolus Therapeutics plc (Nasdaq: AUTL) is an early commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation T cell therapies and candidates for the treatment of cancer and autoimmune disease. Using a broad suite of proprietary and modular T cell programming technologies, Autolus is engineering precisely targeted and controlled T cell therapies that are designed to better recognize target cells, break down their defense mechanisms and eliminate these cells. Autolus has an FDA approved and MHRA licensed product, obe-cel, and a pipeline of product candidates in development for the treatment of hematological malignancies, solid tumors and autoimmune diseases. For more information, please visit www.autolus.com.
Contact:
Amanda Cray
+1 617-967-0207
a.cray@autolus.com
Olivia Manser
+44 7780 471 568
o.manser@autolus.com
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
